Another relevant study demonstrated that knockout of E2F1, E2F2 or E2F3 reduced tumor onset driven by MMTV-ErbB2, with E2F1 or E2F3 ablation having no effects on tumor growth rates and ablation of E2F1 accelerating tumor growth [21]. Here, E2F3 is linked to neoplasm.